Page last updated: 2024-10-24

verapamil and Arteriovenous Malformations, Cerebral

verapamil has been researched along with Arteriovenous Malformations, Cerebral in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joshi, S1
Young, WL1
Pile-Spellman, J1
Fogarty-Mack, P1
Sciacca, RR1
Hacein-Bey, L1
Duong, H1
Vulliemoz, Y1
Ostapkovich, N1
Jackson, T1

Other Studies

1 other study available for verapamil and Arteriovenous Malformations, Cerebral

ArticleYear
Intra-arterial nitrovasodilators do not increase cerebral blood flow in angiographically normal territories of arteriovenous malformation patients.
    Stroke, 1997, Volume: 28, Issue:6

    Topics: Acetylcholine; Adult; Blood Pressure; Calcium Channel Blockers; Cerebral Angiography; Cerebrovascula

1997